The Finance Weekly

DECEMBER 2, 2024

A finance director at a large niche pharmaceutical company told us: “We have a lot of manual processes and inputting and that type of stuff which I am trying to get away from. One company we spoke to–a $110M equipment leasing firm–has been looking for a way out of this Excel mess for three years.

Financial Planning and Analysis (FP&A) 52

Financial Planning and Analysis (FP&A) Finance Data Analysis Financial Modeling 52

Musings on Markets

FEBRUARY 18, 2025

Carrying this through to the real world, you should not be surprised to see technology and pharmaceutical companies, the two biggest spenders on R&D, report much higher accounting returns than they are actually earning on their investments.

Marketing 52

Marketing Profit and Loss Investments Accounting 52

The Finance Weekly

JANUARY 21, 2024

A finance director at a large niche pharmaceutical company told us: “We have a lot of manual processes and inputting and that type of stuff which I am trying to get away from. One company we spoke to–a $110M equipment leasing firm–has been looking for a way out of this Excel hell for three years.

Financial Planning and Analysis (FP&A) 40

Financial Planning and Analysis (FP&A) Finance Data Analysis Financial Modeling 40

Barry Ritholtz

DECEMBER 17, 2024

I was particularly, I was in, I was working in, on the East coast and, you know, any, everything from like pharmaceutical to automotive to, to what a, what a distribution network looked like. The, the, the, the financial financial analysis is the same, effectively, maybe it’s even more intensive on the, on the, on the m and a side.

Technology 52

Technology Investments Numbers Concentration 52